cancer

New Biotechnology Partnership Formed to Develop Liver Cancer Chemotherapeutic

Q BioMed, Inc., a New York City-based biomedical acceleration and development company has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB) to develop a chemotherapeutic technology to treat liver cancer. The technology will utilize “uttroside B” and the compound’s derivatives as a chemotherapeutic agent […]